In addition, IL-1β can augment megakaryocyte and platelet function to promote atherothrombosis via CD121a [22], and Bhaskar et al. have reported that an anti-IL-1β antibody can inhibit the progression of atherosclerosis in vivo [23]. This evidence concerns the gene IL1B and atherosclerosis.